Lenalidomide 25mg capsules
NHS hospitals in England used £54,843,004 of indicative cost of Lenalidomide 25mg capsules in the 12 months to April 2026, about 0.2% of all hospital medicines spend. That is down 6.2% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Lenalidomide 25mg capsules: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Lenalidomide 25mg capsules most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Southend Univ Hosp Nhs Foundation Trust | £1,590,992 |
| Nottingham University Hospitals Trust | £1,454,544 |
| Royal Devon & Exeter Nhs Foundation Trst | £1,408,784 |
| Royal Cornwall Hospitals Nhs Trust | £1,231,152 |
| Imperial College Healthcare Nhs Trust | £1,131,312 |
| East Kent Hospitals University Nhs Ft | £1,109,472 |
| The Royal Marsden Nhs Foundation Trust | £1,073,074 |
| United Lincolnshire Hospitals Nhs Trust | £1,058,512 |
| Co.durham & Darlington Nhs Foundation Tr | £1,052,688 |
| Gloucestershire Hpls Nhs Foundation Trst | £1,050,608 |
The primary-care picture
Lenalidomide is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Lenalidomide medicine page.